The Sudeep Pharma IPO began on 21-November-2025. It will close on 25-November-2025. The Total IPO Size is 895 Crores. The company set its IPO price at 563-593 Rs Per Share.
There are three basic categories in Sudeep Pharma IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.
Sudeep Pharma is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem.
They have expanded their global presence to around 100 countries and established a presence in both, domestic and international markets, including key regions such as the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
They operate three Manufacturing Facilities in Vadodara, Gujarat, with a combined annual manufacturing capacity of 65,579 MT.
Sudeep Pharma IPO Promoters
Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Limited, and Bhayani Family Trust are the promoters of the company.
Sudeep Pharma IPO Date, Details & Price Band
The Sudeep Pharma IPO Price Band, IPO Dates, Market lot and other details mentioned in the table below.
| IPO Opening Dates | 21-November-2025 |
| IPO Closing Dates | 25-November-2025 |
| Price | 563-593 Rs |
| Fresh Issue | 95.00 Cr |
| Offer for sale | 800.00 Cr |
| Total IPO size | 895.00 Cr |
| Face Value | 1 INR Per Share |
| Issue Type | Book Built Issue |
| QIB Allocation | 50% |
| HNI Allocation | 15% |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
| Market Cap | 6,697.85 Cr |
Sudeep Pharma IPO Market Lot
The Sudeep Pharma IPO minimum market lot is 25 shares with a 14,825 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 25 | 14,825 ₹ |
| Retail Maximum | 13 | 325 | 1,92,725 ₹ |
| S-HNI Minimum | 14 | 350 | 2,07,550 ₹ |
| S-HNI Maximum | 67 | 1,675 | 9,93,275 ₹ |
| B-HNI Minimum | 68 | 1,700 | 10,08,100 ₹ |
Restated Consolidated Financial Information (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 30-Jun-25 | 922.26 | 130.08 | 31.27 |
| 31-Mar-25 | 717.17 | 511.33 | 138.69 |
| 31-Mar-24 | 513.87 | 465.38 | 133.15 |
| 31-Mar-23 | 420.11 | 438.26 | 62.32 |
Sudeep Pharma IPO (Object of the Issue)
1. Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I
2. General Corporate Purposes.
Sudeep Pharma IPO GMP & Grey Market Premium
The Sudeep Pharma IPO GMP (Grey Market Premium) has started today. Check the Latest Sudeep Pharma IPO GMP, Kostak Rates, and Subject to Sauda Price here.
Sudeep Pharma IPO Prospectus
The Sudeep Pharma IPO Prospectus is Available on the NSE/BSE and SEBI websites, as well as on our Portal. Please click here to download the Sudeep Pharma IPO Prospectus.
| DRHP | Download |
| RHP | Download |
| Anchor Investor List | Download |
Sudeep Pharma IPO Allotment Date & Details
| Allotment Date | 26-Nov-2025 |
| Initiation of refunds | 27-Nov-2025 |
| Transfer of shares to Demat accounts | 27-Nov-2025 |
| Listing Date | 28-Nov-2025 |
| Check Allotment Status | Click here |
Registrar of Sudeep Pharma
MUFG Intime India Private Limited
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai 400 083
Maharashtra, India
Tel: +91 81 0811 4949
E-mail: [email protected]
Investor Grievance ID: [email protected]
Website: www.in.mpms.mufg.com
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Sudeep Pharma Contact Details
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,
Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: [email protected]
Website: https://www.sudeeppharma.com/
Sudeep Pharma IPO Lead Managers
ICICI Securities Limited
ICICI Venture House,
Appasaheb Marathe Marg Prabhadevi
Mumbai 400 025, Maharashtra, India
Tel.: +91 22 6807 7100
E-mail: [email protected]
Investor Grievance ID: [email protected]
Website: www.icicisecurities.com
Contact Person: Aboli Pitre / Namrata Ravasia
SEBI Registration No.: INM000011179
IIFL Capital Services Limited
24th Floor, One Lodha Place
Senapati Bapat Marg
Lower Parel (West),
Mumbai 400 013
Maharashtra, India
Tel: +91 22 4646 4728
E-mail: [email protected]
Website: www.iiflcap.com
Investor Grievance E-mail: [email protected]
Contact Person: Pawan Jain / Nikita Tayal
SEBI Registration No.: INM000010940
